NO20034837D0 - CRF reseptorantagonister - Google Patents

CRF reseptorantagonister

Info

Publication number: NO20034837D0
Authority: NO; Norway
Prior art keywords: receptor antagonists; crf receptor; crf; antagonists; receptor
Prior art date: 2001-04-30

Application number

NO20034837A

Other languages

English (en)

Other versions

NO20034837L (no

Inventor

Romano Di Fabio

Fabrizio Micheli

Alessandra Pasquarello

Yves St-Denis

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-30

Filing date

2003-10-29

Publication date

2003-10-29

2001-04-30 Priority claimed from GB0110566A external-priority patent/GB0110566D0/en

2001-04-30 Priority claimed from GB0110579A external-priority patent/GB0110579D0/en

2001-07-17 Priority claimed from GB0117423A external-priority patent/GB0117423D0/en

2002-02-11 Priority claimed from GB0203203A external-priority patent/GB0203203D0/en

2003-10-29 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2003-10-29 Publication of NO20034837D0 publication Critical patent/NO20034837D0/no

2003-12-09 Publication of NO20034837L publication Critical patent/NO20034837L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20034837A 2001-04-30 2003-10-29 CRF reseptorantagonister NO20034837L (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GB0110566A GB0110566D0 (en)	2001-04-30	2001-04-30	Chemical compounds
GB0110579A GB0110579D0 (en)	2001-04-30	2001-04-30	Chemical compounds
GB0117423A GB0117423D0 (en)	2001-07-17	2001-07-17	Chemical compounds
GB0203203A GB0203203D0 (en)	2002-02-11	2002-02-11	Chemical compounds
PCT/GB2002/001981 WO2002087573A1 (en)	2001-04-30	2002-04-30	Crf receptor antagonists

Publications (2)

Publication Number	Publication Date
NO20034837D0 true NO20034837D0 (no)	2003-10-29
NO20034837L NO20034837L (no)	2003-12-09

Family

ID=27447943

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034837A NO20034837L (no)	2001-04-30	2003-10-29	CRF reseptorantagonister

Country Status (21)

Country	Link
US (1)	US7329667B2 (no)
EP (1)	EP1383498B1 (no)
JP (1)	JP2004528342A (no)
KR (1)	KR20040015205A (no)
CN (1)	CN1512883A (no)
AR (1)	AR033296A1 (no)
AT (1)	ATE320254T1 (no)
AU (1)	AU2002249474B2 (no)
BR (1)	BR0209035A (no)
CA (1)	CA2446497A1 (no)
CZ (1)	CZ20032945A3 (no)
DE (1)	DE60209885T2 (no)
ES (1)	ES2255610T3 (no)
HU (1)	HUP0304035A2 (no)
IL (1)	IL158063A0 (no)
MX (1)	MXPA03009930A (no)
NO (1)	NO20034837L (no)
NZ (1)	NZ528364A (no)
PL (1)	PL366854A1 (no)
TW (1)	TWI236908B (no)
WO (1)	WO2002087573A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0308208D0 (en)	2003-04-09	2003-05-14	Glaxo Group Ltd	Chemical compounds
CN102459267B (zh)	2009-06-08	2014-11-26	武田药品工业株式会社	用作jak抑制剂的二氢吡咯并萘啶酮化合物
RU2498986C2 (ru) *	2011-07-20	2013-11-20	Учреждение Российской Академии Наук Институт Проблем Химической Физики Ран (Ипхф Ран)	ТЕТРАЦИАНОЗАМЕЩЕННЫЕ 1,4,9b-ТРИАЗАФЕНАЛЕНЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6403599B1 (en)	1995-11-08	2002-06-11	Pfizer Inc	Corticotropin releasing factor antagonists
ZA973884B (en) *	1996-05-23	1998-11-06	Du Pont Merck Pharma	Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
BR9915129A (pt)	1998-11-12	2001-08-07	Neurocrine Biosciences Inc	Antagonistas do receptor de crf e processos relacionados aos mesmos
US6514982B1 (en)	1998-11-12	2003-02-04	Neurocrine Biosciences, Inc.	CRF receptor antagonists and methods relating thereto
GB0117395D0 (en)	2001-07-17	2001-09-05	Glaxo Group Ltd	Chemical compounds

2002
- 2002-04-30 NZ NZ528364A patent/NZ528364A/en unknown
- 2002-04-30 PL PL02366854A patent/PL366854A1/xx not_active Application Discontinuation
- 2002-04-30 JP JP2002584918A patent/JP2004528342A/ja active Pending
- 2002-04-30 WO PCT/GB2002/001981 patent/WO2002087573A1/en not_active Ceased
- 2002-04-30 ES ES02718405T patent/ES2255610T3/es not_active Expired - Lifetime
- 2002-04-30 CN CNA028107454A patent/CN1512883A/zh active Pending
- 2002-04-30 BR BR0209035-0A patent/BR0209035A/pt not_active IP Right Cessation
- 2002-04-30 IL IL15806302A patent/IL158063A0/xx unknown
- 2002-04-30 AU AU2002249474A patent/AU2002249474B2/en not_active Ceased
- 2002-04-30 DE DE60209885T patent/DE60209885T2/de not_active Expired - Fee Related
- 2002-04-30 KR KR10-2003-7014159A patent/KR20040015205A/ko not_active Withdrawn
- 2002-04-30 EP EP02718405A patent/EP1383498B1/en not_active Expired - Lifetime
- 2002-04-30 MX MXPA03009930A patent/MXPA03009930A/es active IP Right Grant
- 2002-04-30 AT AT02718405T patent/ATE320254T1/de not_active IP Right Cessation
- 2002-04-30 HU HU0304035A patent/HUP0304035A2/hu unknown
- 2002-04-30 CZ CZ20032945A patent/CZ20032945A3/cs unknown
- 2002-04-30 CA CA002446497A patent/CA2446497A1/en not_active Abandoned
- 2002-04-30 AR ARP020101598A patent/AR033296A1/es unknown
- 2002-04-30 TW TW091108900A patent/TWI236908B/zh not_active IP Right Cessation
- 2002-04-30 US US10/476,441 patent/US7329667B2/en not_active Expired - Fee Related
2003
- 2003-10-29 NO NO20034837A patent/NO20034837L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AR033296A1 (es)	2003-12-10
DE60209885T2 (de)	2006-08-10
DE60209885D1 (de)	2006-05-11
BR0209035A (pt)	2004-08-10
US7329667B2 (en)	2008-02-12
US20040235871A1 (en)	2004-11-25
ATE320254T1 (de)	2006-04-15
NO20034837L (no)	2003-12-09
MXPA03009930A (es)	2004-01-29
CN1512883A (zh)	2004-07-14
AU2002249474B2 (en)	2006-01-12
JP2004528342A (ja)	2004-09-16
PL366854A1 (en)	2005-02-07
IL158063A0 (en)	2004-03-28
EP1383498B1 (en)	2006-03-15
HUP0304035A2 (hu)	2004-04-28
NZ528364A (en)	2005-12-23
KR20040015205A (ko)	2004-02-18
CA2446497A1 (en)	2002-11-07
TWI236908B (en)	2005-08-01
CZ20032945A3 (cs)	2004-02-18
WO2002087573A1 (en)	2002-11-07
ES2255610T3 (es)	2006-07-01
EP1383498A1 (en)	2004-01-28

Publication	Publication Date	Title
DK1446379T3 (da)	2009-07-27	Arylanilin-beta2-adrenergiske receptoragonister
DE60216229D1 (de)	2007-01-04	Il-8-rezeptorantagonisten
NO20025754D0 (no)	2002-11-29	IL-8 Reseptor-antagonister
ATE439344T1 (de)	2009-08-15	Muscarin-antagonisten
ATE469875T1 (de)	2010-06-15	Nk1-antagonisten
ATE299698T1 (de)	2005-08-15	Il-8 rezeptor antagonisten
SI1425280T1 (sl)	2006-12-31	Hetero-biciklicni antagonisti crf
DE60126480D1 (de)	2007-03-22	Il-8 rezeptor-antagonisten
DE60222693D1 (de)	2007-11-08	Nk1-antagonisten
DE60130000D1 (de)	2007-09-27	Zwitterionische tachykinin-rezeptor-antagonisten
NO20024554D0 (no)	2002-09-23	IL-8 reseptorantagonister
DE60226419D1 (de)	2008-06-19	Somatostatin-antagonisten
DK1180028T3 (da)	2007-05-21	IL-8-receptorantagonister
NO20024367D0 (no)	2002-09-12	IL-8 reseptorantagonister
IS6818A (is)	2003-05-15	Histamín viðtaka mótlyf
NO20015774L (no)	2001-11-27	IL-8 reseptorantagonister
ATE370932T1 (de)	2007-09-15	Ccr-3-rezeptorantagonisten vii
ATE320254T1 (de)	2006-04-15	Crf receptor antagonisten
NO20024366L (no)	2002-10-09	IL-8 reseptorantagonister
SE0003996D0 (sv)	2000-11-01	Receptorantagonister

Legal Events

Date	Code	Title	Description
2007-11-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application